Northstar Advisory Group LLC Invests $1.15 Million in Colgate-Palmolive Company $CL

Northstar Advisory Group LLC acquired a new position in shares of Colgate-Palmolive Company (NYSE:CL) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 14,486 shares of the company’s stock, valued at approximately $1,145,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Copia Wealth Management acquired a new position in Colgate-Palmolive during the third quarter worth about $29,000. Cloud Capital Management LLC bought a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at approximately $30,000. Global Wealth Strategies & Associates increased its position in Colgate-Palmolive by 300.0% during the 4th quarter. Global Wealth Strategies & Associates now owns 400 shares of the company’s stock worth $32,000 after purchasing an additional 300 shares in the last quarter. Grove Bank & Trust increased its position in Colgate-Palmolive by 182.6% during the 4th quarter. Grove Bank & Trust now owns 407 shares of the company’s stock worth $32,000 after purchasing an additional 263 shares in the last quarter. Finally, Kelleher Financial Advisors bought a new position in Colgate-Palmolive in the 3rd quarter valued at approximately $35,000. Institutional investors own 80.41% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the stock. The Goldman Sachs Group reaffirmed a “buy” rating and set a $100.00 target price on shares of Colgate-Palmolive in a research note on Friday, February 20th. Jefferies Financial Group raised their price objective on Colgate-Palmolive from $85.00 to $91.00 and gave the company a “hold” rating in a report on Monday, February 2nd. JPMorgan Chase & Co. boosted their price objective on Colgate-Palmolive from $93.00 to $97.00 and gave the stock an “overweight” rating in a research report on Monday, February 2nd. Evercore increased their target price on Colgate-Palmolive from $94.00 to $100.00 and gave the company an “outperform” rating in a research report on Monday, February 2nd. Finally, Wells Fargo & Company boosted their price target on Colgate-Palmolive from $86.00 to $94.00 and gave the stock an “equal weight” rating in a report on Sunday, February 1st. Twelve investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average price target of $95.25.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock opened at $85.59 on Tuesday. The company has a quick ratio of 0.54, a current ratio of 0.83 and a debt-to-equity ratio of 18.82. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $99.33. The stock has a market cap of $68.67 billion, a price-to-earnings ratio of 32.67, a P/E/G ratio of 3.78 and a beta of 0.28. The company’s fifty day moving average is $91.13 and its 200 day moving average is $83.39.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The business had revenue of $5.23 billion during the quarter, compared to analyst estimates of $5.13 billion. During the same period last year, the company earned $0.91 EPS. Colgate-Palmolive’s revenue for the quarter was up 5.8% compared to the same quarter last year. Sell-side analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Monday, April 20th will be issued a $0.53 dividend. The ex-dividend date is Monday, April 20th. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. This represents a $2.12 annualized dividend and a yield of 2.5%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 79.39%.

Insider Activity

In other news, insider Sally Massey sold 15,851 shares of the stock in a transaction on Thursday, February 5th. The shares were sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the completion of the sale, the insider directly owned 13,751 shares in the company, valued at $1,306,757.53. This represents a 53.55% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Stanley J. Sutula III sold 97,843 shares of the business’s stock in a transaction on Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the completion of the transaction, the chief financial officer owned 55,310 shares in the company, valued at approximately $5,214,073.70. The trade was a 63.89% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 184,683 shares of company stock worth $17,486,693. 0.41% of the stock is owned by company insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.